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PCR Ampliﬁcation from Fixed Tissue Indicates Frequent
Involvement of Brachyspira aalborgi in Human
Intestinal Spirochetosis
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PCR procedures amplifying portions of the 16S rRNA and NADH oxidase genes of Brachyspira aalborgi and
Serpulina pilosicoli were applied to DNA extracted from parafﬁn-embedded human colonic or rectal tissues from
30 Norwegian, Australian, and U.S. patients, 16 of whom had histologic evidence of intestinal spirochetosis
(IS). B. aalborgi-speciﬁc sequences were identiﬁed by PCR in 10 of the IS patients (62.5%) but none of the
others, while S. pilosicoli sequences were not detected in tissues from any patient. Direct sequencing of products
from three of the positive samples provided further conﬁrmation of the presence of B. aalborgi. B. aalborgi may
be a more common cause of intestinal spirochetosis than has been previously thought.
Intestinal spirochetosis (IS) is a condition of humans (4) and
many animal species (8, 35, 37) in which there is a densely
packed attachment of spirochetes by one end to the colonic
epithelium, forming a “false brush border” (15). Generally,
intestinal spirochetes associated with the condition in humans
have not been well characterized (3, 14, 15, 23, 38, 47), al-
though two species, Brachyspira aalborgi (18) and Serpulina
pilosicoli (formerly Anguillina coli) (25, 39, 45, 46), have been
identiﬁed. These species are distinct in a number of morpho-
logic, biochemical, and molecular characteristics. Recently, it
has been proposed that S. pilosicoli be renamed Brachyspira
pilosicoli (28), but it is still a matter of contention whether or
not the two organisms belong to the same genus (17, 34).
The pathogenicity of these organisms is unresolved. There
are a number of reports in which IS, caused by as-then-unchar-
acterized spirochetes, has been associated with a variety of
gastrointestinal disorders, including chronic diarrhea and rec-
tal bleeding (5–7, 12, 13, 15, 21, 24, 31). The one detailed study
in which B. aalborgi was isolated from humans with histologic
evidence of IS, however, suggested that this spirochete is com-
mensal (16). In contrast, there are a number of detailed studies
on S. pilosicoli, including pathogenicity studies, in which strains
isolated from humans have been used to infect and cause
intestinal disease in both chicks and pigs (27, 42, 44). Unlike S.
pilosicoli, B. aalborgi has failed to colonize experimentally in-
fected chicks (41). Thus, it appears that human strains of S.
pilosicoli have pathogenic potential, as do animal strains (35,
37), and this has been reinforced by the recovery of S. pilosicoli
from the bloodstream of a series of critically ill human patients
(43). The potential invasive properties of such organisms have
been highlighted by a series of studies in which unidentiﬁed
spirochetes were observed invading human intestinal epithe-
lium (1, 14, 29) and liver parenchyma (23).
While B. aalborgi has been isolated on only one occasion
from a human, a patient in Denmark (18), and this is the only
strain available for study (513A
T/ATCC 43994
T), S. pilosicoli
has been isolated from humans in the United States (20),
Germany (22), Oman (3), the United Kingdom (25), France
(10), Papua New Guinea (40), and Australia (24, 39). S. pilosi-
coli also naturally infects pigs (36), dogs (40), and chickens
(26).
Although the condition known as IS has been deﬁned from
both a histologic and a microbiologic viewpoint, only two stud-
ies have concurrently examined both aspects, including full
identiﬁcation of the spirochetes involved. In one, B. aalborgi
was isolated from 1 of 5 patients showing evidence of IS (18);
in the other, S. pilosicoli was isolated from 22 of 41 rectal
biopsies (53.7%) showing evidence of IS (39). An inherent
problem in epidemiologic studies applied to intestinal spiro-
chetes has been the selective culturing techniques used to
isolate these fastidious anaerobes before they can be charac-
terized (19). In particular, S. pilosicoli grows more rapidly in
culture than does the single available strain of B. aalborgi, and
the possibility remains that an S. pilosicoli isolate obtained
from a culture may be masking other species or strains of
spirochetes also present in the sample. The study in which S.
pilosicoli was isolated from only 53.7% of human rectal biopsy
specimens showing histologic evidence of IS could be inter-
preted to suggest that other, more fastidious spirochetes, in-
cluding B. aalborgi, may have been present in the culture-
negative specimens (39). Methods of molecular detection and
characterization that can be applied directly to infected tissue
without the need for culture are therefore required in order to
resolve this possibility. The approach taken in the present
study was to apply PCR to DNA extracted from human intes-
tinal biopsies showing evidence of IS, so as to gain further
insight into which spirochete species are predominantly in-
volved in human IS. This information would allow the use of
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2093more appropriate diagnostic techniques for the condition. Tis-
sues from patients without histologic evidence of IS were also
tested, to conﬁrm the speciﬁcity of the tests.
Thirty-one biopsy samples from the large intestines of 30
patients were analyzed by PCR; these included one sample
each from 12 elderly patients in Norway, three samples from 2
human immunodeﬁciency virus (HIV)-positive patients in
Washington, D.C., one sample each from 2 patients in Mel-
bourne, Australia, and one sample each from 14 negative con-
trol patients in Perth, Australia (Table 1). All patients had
symptoms of gastrointestinal disease, which prompted biopsies
being taken to assist with diagnosis (Table 1). Only the two
samples from the patients in Melbourne were cultured, with
the medium and culture conditions recommended for Serpu-
lina spp. (19), and both failed to yield spirochetes. The 17
samples from 16 patients in Norway, the United States, and
Melbourne, Australia, were all selected for testing because
they showed histologic evidence of IS, with a basophilic fringe
of spirochetes attached by one cell end to the intact surface
epithelium (Fig. 1). In the cases of all of the Norwegian and
Australian IS specimens, the epithelial surface was intact and
there was no evidence of inﬂammation in the lamina propria.
TABLE 1. Sources of intestinal samples from 16 patients diagnosed with IS, 14 patients negative for IS, and 3 experimentally infected chicks









with S. pilosicoli Karlos
Cecum 2211
Chick experimentally infected
with S. pilosicoli WesB
Cecum 2211
Chick experimentally infected
with S. intermedia PWS/A
Cecum 2222
South Norway F/37 Colorectal 2222 Spirochetosis; ulcer of the colon
South Norway F/55 Colorectal 2222 Spirochetosis; adenocarcinoma
South Norway F/76 Colorectal 2222 Spirochetosis; adenocarcinoma
South Norway M/67 Colorectal 2222 Spirochetosis; tubulovillous adenoma; diverticulitis
South Norway M/74 Colorectal 2222 Spirochetosis; tubulovillous adenoma
South Norway M/55 Colorectal 1122 Spirochetosis; adenocarcinoma; carcinoid tumor of appendix
South Norway M/60 Colorectal 1122 Spirochetosis; squamous cell carcinoma of the transverse
colon
South Norway M/70 Colorectal 1122 Spirochetosis; adenocarcinoma; diverticulosis
South Norway M/73 Colorectal 1122 Spirochetosis; adenocarcinoma
South Norway M/75 Colorectal 1122 Spirochetosis; adenocarcinoma
South Norway M/76 Colorectal 1122 Spirochetosis; adenocarcinoma
South Norway M/80 Colorectal 1122 Spirochetosis; diverticulitis
United States M/26 Ascending colon 1122 Spirochetosis; HIV
1; 171 CD4 cells/ml; fever; anorexia;
weight loss; cramping abdominal pain; bloody diarrhea
United States M/26 Rectum 1122 Same patient as above
United States M/48 Descending
colon
1122 Spirochetosis; HIV
1; 20 CD4 cells/ml; Kaposi’s sarcoma;
weight loss; alternating watery diarrhea and constipation
without melana; hyperplastic polyps; tubulovillous
adenoma
Melbourne, Australia F/16 Colorectal 1122 Spirochetosis; abdominal pain; otherwise normal
Melbourne, Australia F/9 Rectum 2222 Spirochetosis; PR bleeding; spirochetosis in the past; mild
nonspeciﬁc inﬂammation of the esophagus and stomach;
otherwise normal
Perth, Australia F/45 Random colon 2222 Negative for spirochetosis; iron deﬁciency
Perth, Australia F/45 Transverse
colon
2222 Negative for spirochetosis; diarrhea
Perth, Australia F/47 Rectum 2222 Negative for spirochetosis; polyps; family history of
carcinoma
Perth, Australia F/54 Cecum 2222 Negative for spirochetosis; abdominal pain
Perth, Australia F/65 Descending
colon
2222 Negative for spirochetosis; diarrhea
Perth, Australia F/78 Sigmoid 2222 Negative for spirochetosis; adenoma, diverticuli
Perth, Australia M/36 Left colon 2222 Negative for spirochetosis; change in bowel habit
Perth, Australia M/39 Sigmoid colon 2222 Negative for spirochetosis; diarrhea?; polyp
Perth, Australia M/41 Right colon 2222 Negative for spirochetosis; change in bowel habit
Perth, Australia M/43 Middle colon 2222 Negative for spirochetosis; diarrhea
Perth, Australia M/69 Rectum 2222 Negative for spirochetosis; polyp
Perth, Australia M/74 Sigmoid colon 2222 Negative for spirochetosis; minor inﬂammatory changes
(history of Crohn’s disease)
Perth, Australia M/75 Rectum 2222 Negative for spirochetosis; polyp
Perth, Australia M/77 Rectum 2222 Negative for spirochetosis; polyp
a F, female; M, male. Ages are given in years.
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the samples from the two U.S. patients both showed inﬂam-
matory inﬁltrates, and electron microscopic examination re-
vealed the presence of spirochetes within foamy macrophages
in the lamina propria and in mucosal epithelial cells. The 14
samples from Perth were selected for testing as negative con-
trols because they did not show histologic evidence of IS.
These patients had a variety of other intestinal disorders (Ta-
ble 1). Three other cecal samples from chicks which had been
experimentally infected with strains of S. pilosicoli isolated
from humans (strains Karlos or WesB [41]) or Serpulina inter-
media (porcine strain PWS/A
T [32]) were also included as
controls (Table 1). The former two were positive controls for S.
pilosicoli, while the latter was a further negative control. No
positive tissue controls from infected chicks were available for
B. aalborgi, because this organism fails to colonize chicks (41).
All samples had been routinely ﬁxed in 10% phosphate-buff-
ered formalin, dehydrated, and embedded in parafﬁn wax. The
samples from the two chicks infected with S. pilosicoli showed
histologic evidence of IS, with a false brush border of spiro-
chetes being evident, as previously described (41).
DNA from parafﬁn-embedded tissue (PET) samples was
extracted by a modiﬁcation of a previously described method
(11). PET samples were sliced into 15- to 20-mm sections with
a microtome blade, which was thoroughly cleaned between
samples. Negative control chick samples were cut between
sequential human samples. Each section was dewaxed by plac-
ing it in 200 ml of xylene and then on a rocker for 5 min at room
temperature. The samples were then centrifuged at 10,000 3 g
for 10 min, and the supernatant was discarded. A second xy-
lene incubation was performed, and 200 ml of 100% ethanol
was added, incubated, and centrifuged, as for xylene. A second
ethanol incubation and centrifugation was performed, the su-
pernatant was discarded, and the samples were dried at 50°C in
an oven for 30 min. Twenty micrograms of proteinase K
(Boehringer GmbH, Mannheim, Germany) in 100 mlo f5 0m M
Tris-HCl, pH 8.3, was added and incubated overnight at 37°C.
The samples were then boiled for 8 min, and 1 ml of each
resultant extract was used as template DNA for PCR analysis.
The 16S rRNA gene sequences of B. aalborgi 513
T and S.
pilosicoli P43/6/78
T, HRM-7A, and WesB (accession no.
Z22781, U23032, Y10314, and unsubmitted, respectively), as
well as the NADH oxidase (nox) gene sequences for these
strains (accession no. AF060816, AF060807, AF060806, and
AF060808, respectively), were obtained from the GenBank
sequence database. Pairs of primers to speciﬁcally detect the
presence of the B. aalborgi 16S rRNA gene, the S. pilosicoli 16S
rRNA gene, the B. aalborgi nox gene, and the S. pilosicoli nox
gene were designed from these sequences by using SeqEd
(version 1.0.3; Applied Biosystems, Foster City, Calif.) and
Amplify (version 1.2; University of Wisconsin, Madison, Wis.).
The only exception was the previously described forward
primer Acoli 1, used in detection of the S. pilosicoli 16S rRNA
gene, which had been designed in our laboratory (30). Four
separate PCR protocols were utilized with the primers, ther-
mocycling conditions, and predicted product sizes outlined in
Table 2.
All ampliﬁcation mixtures consisted of a 25-ml reaction mix
of 13 PCR buffer, 0.55 U of Tth Plus DNA polymerase, 1.5
mM of MgCl2 (Biotech International Ltd, Bentley, Western
Australia, Australia), 5 nmol of each deoxynucleoside triphos-
phate (Amersham Pharmacia Biotech AB, Uppsala, Sweden),
and 12.5 pmol of each primer (Table 2). Three percent (vol/
vol) dimethyl sulfoxide (Sigma-Aldrich Co., St. Louis, Mo.)
was also added, and the reaction was separated into two phases
by the addition of 20 ml of Chill-out 14 liquid wax (MJ Re-
search Inc, Watertown, Mass.) phase separator to facilitate a
hot start PCR, as previously described (2). The PCR products
were subjected to electrophoresis in 1.5% (wt/vol) agarose gels
in 13 Tris-acetate buffer, stained with ethidium bromide, and
viewed over UV light.
The speciﬁcities of the PCRs were conﬁrmed by testing each
on DNA extracted from pure cell cultures of intestinal spiro-
chetes obtained from the collection at the Reference Centre
for Intestinal Spirochetes, Murdoch University. These in-
cluded B. aalborgi 513A
T; S. pilosicoli P43/6/78
T, HRM-2B, “S.
jonesii,” Karlos, Oman-26, and WesB; S. intermedia PWS/A
T;
Serpulina hyodysenteriae B78
T; and Serpulina innocens B256
T
(25). Further conﬁrmation of the speciﬁcities of the reactions
when applied to biopsies was obtained by sequencing of PCR
products. 16S rRNA and nox PCR products to be sequenced
(Table 2) were puriﬁed with a commercially available kit
FIG. 1. Photomicrograph of parafﬁn-embedded rectal biopsy tissue from a Norwegian patient (male, 60 years old) showing a false brush border of spirochetes
subsequently shown by PCR to be B. aalborgi, attached by one end to the mucosa. Bar, 10 mm; stain, hematoxylin and eosin.
VOL. 37, 1999 NOTES 2095(QIAquick PCR puriﬁcation kit; QIAGEN GmbH, Hilden,
Germany), according to the manufacturer’s speciﬁcations. One
ampliﬁed product from biopsies taken from each of the three
geographic regions (Australia, Norway, and the United States)
was sequenced with the previously described primer pairs (Ta-
ble 2) with a commercially available cycle sequencing kit (ABI
PRISM dye terminator cycle sequencing ready reaction kit;
Applied Biosystems), according to the manufacturer’s speciﬁ-
cations. The sequence data obtained were aligned and com-
pared with previously published sequences of the B. aalborgi
and S. pilosicoli 16S rRNA and nox genes obtained from Gen
Bank with SeqEd.
Both PCRs designed to amplify DNA from B. aalborgi gen-
erated a product, which was consistent with the predicted size
(Table 2), from 11 of 17 PET DNA extracts (65%) from human
biopsy material that had histologic evidence of IS. The S.
pilosicoli-speciﬁc PCRs generated products only from the two
positive control chick samples (Table 1), again of the predicted
size (Table 2). No ampliﬁcation was obtained from tissues
from the chick infected with S. intermedia, nor from colonic
tissues obtained from the 14 Australian patients who had no
histologic evidence of IS. Of the 11 positive human samples,
two belonged to the same patient, a 26-year-old HIV positive
male from the United States. Therefore, 10 of 16 IS patients
(62.5%) showed evidence of colonization by B. aalborgi. Seven
of the 12 patients (58%) from South Norway, both patients
(100%) from the United States, and 1 of 2 Australian patients
from Melbourne (50%) were positive for B. aalborgi. The re-
sults for the four PCRs correlated completely, although the
amount of PCR product generated varied between samples.
Negative results from the 14 non-IS patients helped to dem-
onstrate the speciﬁcity of the reactions and showed that B.
aalborgi is not present at detectable levels in patients who lack
histologic evidence of IS.
The PCR products sequenced with the B. aalborgi primers
for both the 16S rRNA and nox genes were identical or closely
related to the corresponding B. aalborgi sequences (Table 3).
The 16S rRNA PCR products from the three PET samples that
were sequenced were identical to the corresponding B. aalborgi
(513
T) sequence over the 449 bp of sequence that was com-
pared. In contrast, they differed from the corresponding S.
pilosicoli (P43/6/78
T) sequence in 41 of 449 bp (90.9% similar-
ity). An even greater divergence was found when the corre-
sponding nox sequences were compared over 325 bp, with the
three PET samples having 98.8 to 99.4% similarity to B. aal-
borgi and 80.0 to 80.3% similarity to S. pilosicoli (Table 3).
The PCR techniques utilized in this study were designed to
speciﬁcally detect the presence of either B. aalborgi or S. pi-
losicoli DNA in extracts from PET. Ampliﬁcation of the nox
gene was selected to conﬁrm the results of 16S rRNA PCR, as
the nox gene is less conserved than the 16S rRNA gene and is
known to be present in strains throughout the genus Serpulina
(33). Care was taken to ensure that the PCR products did not
exceed 500 bp, due to the likelihood of the DNA in the PET
being highly fragmented. A problem faced when developing
primers for B. aalborgi is that only one strain of B. aalborgi is
available, and so only the sequences from this strain could be
used and only one cultured strain could be tested. The primers
appeared to be speciﬁc, however, as they did not amplify DNA
extracted directly from cultured S. pilosicoli strains. In com-
parison, the S. pilosicoli-speciﬁc primers were designed and
tested with a relatively large number of positive control strains,
as well as with positive control intestinal tissues from chicks.
From the results of the present study, it appears that B.
aalborgi may be more commonly involved and more signiﬁcant
in IS than has been suggested. A recent study in Sydney based
on rectal biopsies from male homosexual volunteers showing
histologic evidence of IS pointed to S. pilosicoli as being the
predominant causative agent of the condition (39). However,
selective culturing was used to obtain the spirochetes, and as S.
pilosicoli grows much more readily than the single available
strain of B. aalborgi on the selective agar which is routinely
used for isolation of intestinal spirochetes, failure to detect B.
aalborgi may simply be the result of unsuitable diagnostic
TABLE 2. Primers and thermocycling conditions for B. aalborgi- and S. pilosicoli-speciﬁc reactions
a
PCR test Primer sequence (name) Predicted product
size (bp) Thermocycling program
B. aalborgi 16S rRNA 59-TAC CGC ATA TAC TCT TGA C-39 (F Ba
16S)
472 94°C for 4.5 min; (94°C for 30 s, 46°C for 30 s,
72°C for 30 s) 3 33 cycles
59-CCT ACA ATA TCC AAG AAC C-39 (R Ba
16S)
B. aalborgi nox 59-GGT TGA CTC AAG CAC TAC-39 (F Ba nox) 334 94°C for 4.5 min; (94°C for 30 s, 46°C for 30 s,
72°C for 30 s) 3 30 cycles




59-AGA GGA AAG TTT TTT CGC TTC-39
(Acoli 1)
196 94°C for 4.5 min; (94°C for 30 s, 51°C for 30 s,
72°C for 30 s) 3 33 cycles
59-GTC GCT CCA TCA GAC TTT-39 (R Sp 16S)
S. pilosicoli nox 59-GTA ACT CCT CCT ATT GAG-39 (F Sp nox) 465 94°C for 4.5 min; (94°C for 30 s, 45°C for 30 s,
72°C for 30 s) 3 30 cycles
59-GCA CCA TTA GGT AAA GTC-39 (R Sp nox)
a All reactions were performed on an Applied Biosystems 2400 thermocycler.
TABLE 3. Similarities between PET PCR product sequences






% Similarity of 16S
rRNA PCR products
(449 bp)
% Similarity of nox PCR
products (325 bp)
B. aalborgi S. pilosicoli B. aalborgi S. pilosicoli
Australia (F/16) 100 90.9 98.8 80.3
Norway (M/60) 100 90.9 98.8 80.0
United States (M/26) 100 90.9 99.4 80.0
B. aalborgi 90.9 80.0
2096 NOTES J. CLIN.M ICROBIOL.methods. For example, the medium originally used to obtain
the B. aalborgi isolate in Denmark contained the antibiotics
spectinomycin and polymyxin (18), while more recent culture
studies have used a combination of spectinomycin, colistin, and
vancomycin (40) or spectinomycin alone (39). Secondly, a PCR
speciﬁc for B. aalborgi was not applied in the Sydney study;
thirdly, it focused on rectal biopsies, and it may be that S.
pilosicoli more commonly colonizes this site. Interestingly, the
results from the study based in Sydney, where S. pilosicoli was
isolated by culture from only 53.8% of biopsy specimens show-
ing evidence of IS, suggested that the true prevalence of in-
fection with intestinal spirochetes is underestimated by culture
alone. In the present study, ﬁve of the Norwegian IS patients,
as well as one of the Australian IS patients, failed to return a
positive PCR result for any of the primers (Table 1) despite
clear histologic evidence of IS in the sections (Fig. 1). This
could have been because there was insufﬁcient speciﬁc DNA in
the piece of tissue that was processed for PCR, because the
target DNA was too damaged and/or fragmented to be ampli-
ﬁed, or because the patients were infected by other, as-yet-
uncharacterized spirochetes.
The only other study that has used B. aalborgi- and S. pilosi-
coli-speciﬁc PCRs applied them to PET colonic samples from
nonhuman primates (9). Both B. aalborgi and S. pilosicoli DNA
was detected in some samples, and in some cases concurrently.
The PCRs for S. pilosicoli used in the present study have been
shown to work on animal tissues heavily colonized by the
spirochete, but no ampliﬁcation was obtained from the human
material. Again, it may be that S. pilosicoli was present but in
numbers too low to be detected by the PCR techniques used in
this study. The negative PCR results for both S. pilosicoli and
B. aalborgi in the 14 patients without histologic evidence of IS
suggest that these organisms are uncommon in the general
population.
Where colonization with B. aalborgi did occur, it generally
failed to cause pathologic changes, although in the two U.S.
HIV patients there was invasion of the colonic mucosa by the
spirochetes, together with an inﬂammatory response (14). In
this case, IS was considered to be at least a contributing factor
to the diarrhea and bloody stools experienced by one of the
patients (14). This is similar to the situation reported for S.
pilosicoli in rectal biopsies (39), although under certain circum-
stances the organism seems to be invasive (42–44). It may be
that predisposing factors such as immunosuppression are re-
quired before the spirochetes become invasive.
This study is the ﬁrst since B. aalborgi was recognized in 1982
that has conﬁrmed it as an etiologic agent of human IS. Fur-
thermore, evidence of infection with this organism has been
obtained from patients in Norway, Australia, and the United
States, suggesting that B. aalborgi is widespread in human
populations and that the original isolate was typical of the
species. It will be important to extend these studies with fur-
ther samples and in particular to determine whether, and at
what prevalence, the organism colonizes individuals in devel-
oping regions of the world, where S. pilosicoli is ubiquitous.
The present results also suggest that signiﬁcant limitations are
present in the selective culturing techniques currently em-
ployed in the diagnosis of IS and that these techniques require
reﬁnement.
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